Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
about
Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biopsy proportion of tumour pr ...... lts from the UK MRC OE02 trial
@en
Biopsy proportion of tumour pr ...... lts from the UK MRC OE02 trial
@en-gb
Biopsy proportion of tumour pr ...... ts from the UK MRC OE02 trial.
@nl
type
label
Biopsy proportion of tumour pr ...... lts from the UK MRC OE02 trial
@en
Biopsy proportion of tumour pr ...... lts from the UK MRC OE02 trial
@en-gb
Biopsy proportion of tumour pr ...... ts from the UK MRC OE02 trial.
@nl
prefLabel
Biopsy proportion of tumour pr ...... lts from the UK MRC OE02 trial
@en
Biopsy proportion of tumour pr ...... lts from the UK MRC OE02 trial
@en-gb
Biopsy proportion of tumour pr ...... ts from the UK MRC OE02 trial.
@nl
P2093
P2860
P50
P356
P1154
2-s2.0-84999040455
P1433
P1476
Biopsy proportion of tumour pr ...... lts from the UK MRC OE02 trial
@en
P2093
Alexander I Wright
Gordon G Hutchins
Jeremy D Hayden
Matthew D Hale
Matthew Nankivell
Nicholas P West
Ruth E Langley
Sally P Stenning
William H Allum
Wolfram Mueller
P2860
P304
77565-77575
P356
10.18632/ONCOTARGET.12723
P407
P5530
P577
2016-10-18T00:00:00Z
P6179
1048163831